[RNA polymerase activity of Ehrlich ascites carcinoma nuclei in relation to the mechanism of action of N-alkyl-N-nitrosourea].
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D002467:Cell Nucleus / Q000201:enzymology; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism*; D003609:Dactinomycin / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D008345:Manganese / Q000494:pharmacology; D051379:Mice; D009183:Mycotoxins / Q000494:pharmacology; D009368:Neoplasm Transplantation; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012293:Rifampin / Q000494:pharmacology
D009183:Mycotoxins; D009607:Nitrosourea Compounds; D000644:Quaternary Ammonium Compounds; D012334:RNA, Neoplasm; D003609:Dactinomycin; D008345:Manganese; D012321:DNA-Directed RNA Polymerases; D008274:Magnesium; D012293:Rifampin
Issledovanie RNK-polimeraznoĭ aktivnosti iader astsitnoĭ kartsinomy Erlikha v sviazi s izucheniem mekhanizma deĭstviia N-alkil-N-nitrozomochevin.